OrthoFe · Checked.be

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of OrthoFe is 0.2% (very low). The 2025 annual accounts show equity of €196k and a net result of €343k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 26% of 2219 sector peers (fiscal year 2025). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 4 annual accounts.

Signals

1 signal · with evidence

Consistently profitable

Positive net result in the two most recent financial years (2024 and 2025).

View the result trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-03-2026, 126 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.

The next deadline is still running

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.

How we compute the deadline

The year end is derived from 4 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2025, that is 31-07-2026.

Deadline per financial year

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	27-03-2026	126 d early	2026-00063785
31-12-2024	31-07-2025	17-07-2025	14 d early	2025-00280140
31-12-2023	31-07-2024	18-07-2024	13 d early	2024-00256382
31-12-2022	31-07-2023	22-08-2023	22 d late	2023-00340537

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals

More than 3 years active

Founded in 2022, past the statistically most fragile first 3 years.

No legal incidents

No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone

0.2% Very low

0%0,5%1,5%4%10%≥25%

Lower-failure-rate sector −Young company +Annual accounts: healthy financial profile −

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)

EBIT marginNot published (abbreviated filing)

Net result€343k+16.9%

Working capital€-38k

CSV export

Annual accounts & ratios

Source: NBB · 2025

Annual accounts filed on 27-03-2026 with the NBB · fiscal year 2025 · micro

Operating resultNet result

Trajectory (indicative)

Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.

volatile Too volatile to project: the yearly deviation from the trend is ~54% of the level (threshold 35%). We therefore deliberately show no projection line.

How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison

Fiscal year 2025 · NACE 86, Human health · compared within the same schema type (micro schema)

Metric	This company	Sector median	Position in the sector
Solvency	15.3%	58.2%	better than 26% of 2219 sector peers
Net result	€343k	€60k	better than 95% of 2217 sector peers
Equity	€196k	€74k	better than 76% of 2219 sector peers
Gross operating margin	€484k	€95k	better than 95% of 2219 sector peers
Total assets	€1.28M	€187k	better than 95% of 2219 sector peers

Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.

Sector position over time

Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).

Solvency P26

Weakening position over 2022-2025 · n=2219-6584

Net result P95

Improving position over 2022-2025 · n=2217-6578

Equity P76

Improving position over 2022-2025 · n=2219-6584

Gross operating margin P95

Improving position over 2022-2025 · n=2219-6586

Describes the position versus peers, not a forecast.

EBITDA

€484k

+21.0% 22-25

Net profit

€343k

+16.9% 22-25

Cash flow

€365k

+19.0% 22-25

Total assets

€1.28M

+67.6% 22-25

Equity

€196k

-64.6% 22-25

Working capital

€-38k

- 22-25

Income taxes

€111k

+19.3% 22-25

Dividends

€700k

+27900.0% 22-25

Show 10 other metrics

Debt

€1.09M

+413.2% 22-25

Debt ≤ 1y

€752k

+2328.4% 22-25

Debt > 1y

€330k

+82.7% 22-25

Current ratio

0.95

-94.3% 22-25

Quick ratio

0.95

-94.3% 22-25

Solvency

15.3%

-78.9% 22-25

Debt / equity

5.55

+1349.9% 22-25

ROE

175.2%

+230.2% 22-25

ROA

26.8%

-30.3% 22-25

Interest coverage

42.05

-80.4% 22-25

Figures by fiscal year

Highlight YoY changes (±10%)

Fiscal year	2025
Deposit	micro
Revenue	-
EBITDA	€484k
Net profit	€343k
Cash flow	€365k
Staff costs	-
Income taxes	€111k
Dividends	€700k
Total assets	€1.28M
Equity	€196k
Debt	€1.09M
of which ≤ 1y	€752k
of which > 1y	€330k
Working capital	€-38k
Employees (FTE)	-

Ratios (computed)

	2025
Current ratio	0.95
Quick ratio	0.95
Working capital ratio	-3.0%
Solvency	15.3%
Debt / equity	5.55
Long-term debt ratio	1.69
Interest coverage	42.05
Gross margin	-
Net margin	-
ROA	26.8%
ROE	175.2%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Balance-sheet composition 2025

Assets

Fixed assets €568k · 44.3% Current assets €714k · 55.7%

Equity & liabilities

Equity €196k · 15.3% Debt €1.09M · 84.7%

Full annual accounts (23 line items)

Filed balance sheet and income statement, exactly as deposited with the NBB.

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€1.28M
Fixed assets	21/28	€568k
Tangible fixed assets	22/27	€568k
Current assets	29/58	€714k
Amounts receivable within one year	40/41	€49k
Investments	50/53	€550k
Cash & bank	54/58	€110k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€1.28M
Equity	10/15	€196k
Contributions / capital	10/11	€5k
Reserves	13	€191k
Amounts payable	17/49	€1.09M
Amounts payable after one year	17	€330k
Amounts payable within one year	42/48	€752k
Trade debts payable within one year	44	€1k
Income statement
Gross operating margin	9900	€484k
Operating result	9901	€461k
Financial income	75	€3k
Financial charges	65	€12k
Result before taxes	9903	€453k
Income taxes	67/77	€111k
Net result for the period	9904	€343k
Result to be appropriated	9905	€343k

This table shows the latest fiscal year. 3 prior years, with figures and ratios, belong to a paid plan. See plans →

Ratios computed by Checked.

Health barometer

FY 2025 · computed

53 / 100 Fair

050100

Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →

Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

from the Crossroads Bank

Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Dorp 413221 Holsbeek

Establishment units

1 location

OrthoFe

Hooghuis 24A, 3221 HolsbeekActiviteiten van tandartspraktijken

since 20222.334.122.975

Physical sites registered in the Crossroads Bank for Enterprises (CBE).

Parcels2

Ground area3,915 m²

Buildings2

Building footprint368 m²

Volume (LiDAR)195 m³

Tallest building7.6 m

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 2 (100%)